• Home
  • About Us
    • About us
    • Scientific Advisory Board
    • People
    • Business Strategy
    • Event Calendar
  • Development
    • Portfolio
    • APTA-1
    • Intellectual property and patent
    • What is sepsis?
  • Market
    • Sepsis
    • Clinical application
  • Investor Relations
    • Company Information
    • Financial Information
    • Largest Shareholders
    • Financial Calendar
    • Presentations
  • News
    • World Sepsis Day
  • Contact
  • en
  • sv
  • Home
  • About Us
    • About us
    • Scientific Advisory Board
    • People
    • Business Strategy
    • Event Calendar
  • Development
    • Portfolio
    • APTA-1
    • Intellectual property and patent
    • What is sepsis?
  • Market
    • Sepsis
    • Clinical application
  • Investor Relations
    • Company Information
    • Financial Information
    • Largest Shareholders
    • Financial Calendar
    • Presentations
  • News
    • World Sepsis Day
  • Contact
  • en
  • sv

Archives

Home / 2022 / May
  0
By Erika Medin
In News
Posted 23 May 2022

BioStock article: Aptahem signs agreement with CRO for phase I studies

BioStock published an article on 23 May 2022 about Aptahem, which can be read in full below. Aptahem has entered into an agreement with a clinical contract research organisation in the [...]

READ MORE
  0
By Erika Medin
In News
Posted 17 May 2022

Aptahem enters agreement with international clinical CRO for phase 1 studies with Apta-1

Aptahem (publ) announces today that the company has signed an agreement with the clinical contract research organization (CRO) The Centre for Human Drug Research (CHDR) in the Netherlands to [...]

READ MORE
  0
By Erika Medin
In News
Posted 9 May 2022

Aptahem enters new consortium financed by the KK Foundation

Aptahem (publ) today announce that the company enters a consortium together with Örebro University, Attgeno AB, BioReperia AB, Buzzard Pharmaceuticals AB, Lipum AB, Thermo Fisher Scientific och [...]

READ MORE
Contact



Norra Vallgatan 58, 4 TR
211 22 Malmö
Sweden
E-mail: info@aptahem.com

Aptahem is supporting Global Sepsis Alliance
To all salesmen:

We kindly decline all direct contact with salesmen of different types of products and services.

Copyright All Rights Reserved © 2016

Start typing and press Enter to search